H&R Block to Release Fiscal Third Quarter Results on March 5, 2020
KANSAS CITY, Mo., Feb. 18, 2020 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB) will report fiscal 2020 third quarter […]
AMG Announces Investment in Comvest Partners
Partnership with Comvest increases AMG’s exposure to fast-growing private marketsAMG to participate in attractive middle-market private debt and equity areas […]
Exagen to Present at Cowen and Company 40th Annual Healthcare Conference
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for […]
EDAP Showcases Focal One at the 12th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
LYON, France, February 18, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, […]
La filiale d’AgraFlora, Farmako GmbH, obtient une licence spéciale autorisant la vente de cannabis médical traité par irradiation
VANCOUVER, Colombie-Britannique, Feb. 18, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE : AGRA) (Frankfurt: PU31) […]
Energy Focus Awarded $3.4 Million LED Lighting Contract for the U.S. Navy Fleet
SOLON, Ohio, Feb. 18, 2020 (GLOBE NEWSWIRE) — Energy Focus, Inc. (NASDAQ: EFOI), a leader in sustainable LED lighting technologies, announced […]
Stryker named to the 100 Best Companies to Work For list for 10th consecutive year
Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) — Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the […]
SWM ANNOUNCES AGREEMENT TO ACQUIRE TEKRA, LLC AND TRIENT, LLC, LEADING CONVERTERS OF HIGH-PERFORMANCE FILMS
Alpharetta, GA, Feb. 18, 2020 (GLOBE NEWSWIRE) — SWM (NYSE: SWM) today announced the signing of a definitive agreement to […]
NextCure to Present at 9th Annual SVB Leerink Global Healthcare Conference
BELTSVILLE, Md., Feb. 18, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
Foamix Announces Integrated Efficacy Results from the FMX103 1.5% Topical Minocycline Foam Phase 3 Program for Rosacea
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 18, 2020 (GLOBE NEWSWIRE) — Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), […]
